| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Collegium Pharmaceutical, Inc. (COLL) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. COLL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.13M | $109.24M | - | |
| CFO | 126.7K | $4.42M | - | |
| VP | 121.2K | $4.23M | - | |
| CEO | 97.0K | $3.38M | - | |
| Dir | 95.0K | $3.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2019 | Heffernan Michael Thomas | Director | Sell | 25,000 | $15.56 | $389,000.00 | -8.0% | |
| Dec 17, 2018 | Heffernan Michael Thomas | Director | Sell | 25,000 | $18.18 | $454,490.85 | -3.8% | |
| Nov 15, 2018 | Heffernan Michael Thomas | Director | Sell | 25,000 | $16.60 | $415,122.00 | -3.6% | |
| Oct 15, 2018 | Heffernan Michael Thomas | Director | Sell | 25,000 | $16.53 | $413,250.00 | -6.5% | |
| Jun 21, 2018 | Brannelly Paul | Executive Vice President &CFO | Sell | 10,000 | $27.92 | $279,165.00 | -3.8% | |
| Jun 12, 2018 | Fleming Alison B | Chief Technology Officer | Sell | 4,096 | $27.00 | $110,592.00 | -7.1% | |
| Jun 12, 2018 | Heffernan Michael Thomas | Chairman, President And CEO | Sell | 150,000 | $25.27 | $3,790,938.86 | -15.3% | |
| Jun 1, 2018 | Ciaffoni Joseph | Chief Operating Officer | Sale+OE | 79,683 | $22.59 | $1,799,712.87 | -20.3% | |
| May 10, 2018 | Heffernan Michael Thomas | Chairman, President And CEO | Sell | 7,100 | $26.21 | $186,100.00 | -0.7% | |
| Apr 19, 2018 | Heffernan Michael Thomas | Chairman, President And CEO | Sell | 44,400 | $26.00 | $1,154,401.00 | -3.9% |